The State of Weight-Loss Drugs
Motley Fool Money
Intro
This chapter examines the financial landscape of the burgeoning weight-loss drug market, valued at $150 billion. It highlights the science, potential side effects, and the influence of telehealth on accessibility to GLP-1 medications.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
